Serum exocrine pancreas enzymes are biomarkers of immunotherapy response in new-onset type 1 diabetes

IntroductionThe immune-mediated destruction of insulin-producing β-cells characterizes type 1 diabetes. Nevertheless, exocrine pancreatic enzymes, including amylase, lipase, and trypsin, are also significantly reduced in type 1 diabetes. With an immunotherapy now approved to treat early-stage type 1...

Descrición completa

Detalles Bibliográficos

Principais autores:	Brittany Sorensen Bruggeman, Savanna Gornisiewicz, Rhonda Bacher, Kieran McGrail, Martha Campbell-Thompson, Clive Wasserfall, Laura M. Jacobsen, Mark Atkinson, Michael J. Haller, Desmond A. Schatz
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Endocrinology
Assuntos:	type 1 diabetes exocrine pancreas immunotherapy thymoglobulin granulocyte colony stimulating factor pancreatic alpha-amylase
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1497373/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!